MDACC Study Summary 2004-0578 (Archived)

Study Summary
No. 2004-0578:.......Advanced Cancers; Anus; Bladder; Bone; Brain; Breast; Cervix; CNS; Colon; Colorectal; Endocrine; Endometrial; Esophageal; Eye; Gastric; Gastrointestinal; Genitourinary; Gynecology; Head And Neck; Kidney; Leukemia; Liver; Lung; Lymphoma; Melanoma; Myeloma; Ovary; Pancreas; Prostate; Rectum; Sarcoma; Skin; Small Bowel; Solid Tumors; Spinal; Testis; Thyroid; Unknown Primary; Uterus......Isis W Gayed......Nuclear Medicine

Study Summary Title



Study Summary Number:	2004-0578

Study Title:	Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG whole body PET/CT Scans for tumor staging

Physician

New Patient Referral



Name:	Isis W Gayed	Patients Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Dept:	Nuclear Medicine	Referring MD Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Phone:	713-745-5152 Contact us about clinical trials

General Information



Disease Group:	Advanced Cancers Anus Bladder Bone Brain Breast Cervix CNS Colon Colorectal Endocrine Endometrial Esophageal Eye Gastric Gastrointestinal Genitourinary Gynecology Head And Neck Kidney Leukemia Liver Lung Lymphoma Melanoma Myeloma Ovary Pancreas Prostate Rectum Sarcoma Skin Small Bowel Solid Tumors Spinal Testis Thyroid Unknown Primary Uterus	Supported By:	N/A

Phase of Study:	N/A	Return Visit:	Only to complete their standard of care PET/CT and RVG imaging.

Treatment Agents:	None	Home Care:	N/A

Treatment Loc:	Only at MDACC

Estimated Length of Stay in Houston:	Patients will not require hospitalization


Description/ Intervention:	The goal of this research study is to compare the results, called an ejection fraction, of PET/CT and NM cardiac scans of your heart.

Study Objectives / Outcomes

Evaluate the agreement between radionuclide ventriculography (RNV) and gated F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in calculating left ventricular ejection fraction (LVEF), end diastolic volume (EDV) and end systolic volume (ESV).

Study Status Information



Study Activation / Registration Date:	09/22/2004

IRB Review and Approval Date:	08/18/2004

Study Type:	Not Applicable

Recruitment Status:	Terminated

Projected Accrual:	N/A

Enrollment Eligibility

If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:

1) Patients undergoing both FDG PET/CT scan and RNV within two weeks interval, whether for initial staging, restaging or to evaluate response to therapy.

2) Patients who would consent to an additional 10-15 minutes acquisition of the gated images after completion of their FDG PET/CT study with the additional radiation exposure.

3) Patients with regular heart rate.

Exclusion Criteria:

1) Blood glucose level above 200 mg/dL.

2) Irregular heart rate.

3) An interval of less than 1 day between the FDG PET/CT scan and RNV.

Links

Registration Number: NCT00499382
Study Information on Clinical Trials Registry (clinicaltrials.gov)